Hypopharyngeal cancer is cancer that begins in the hypopharynx, the lowest part of the throat where the larynx and esophagus meet. Risk factors for developing hypopharyngeal cancer include tobacco use, a poor diet, plummer-vinson syndrome, and excessive use of alcohol. There are four different stages of hypopharyngeal cancer that reflect variations in severity. Treatments for hypopharyngeal cancer include radiation therapy, chemotherapy, and surgery. Survival rates for a 5-year survival for this type of cancer are less than 50%.
Hypopharyngeal Cancer Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Hypopharyngeal Cancer below!
For more information on how to use Laverne, please read the How to Guide.
We have 1746 products for the study of Hypopharyngeal Cancer that can be applied to Western Blot, Chromatin Immunoprecipitation, Immunocytochemistry/Immunofluorescence, Flow Cytometry, Chromatin Immunoprecipitation (ChIP), Immunohistochemistry from our catalog of antibodies and ELISA kits.